KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Encompass Health (EHC) Equity Income (2016 - 2025)

Historic Equity Income for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $1.2 million.

  • Encompass Health's Equity Income rose 7142.86% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.0 million for FY2024, which is 625.0% down from last year.
  • According to the latest figures from Q3 2025, Encompass Health's Equity Income is $1.2 million, which was up 7142.86% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Equity Income ranged from a high of $1.4 million in Q2 2024 and a low of $200000.0 during Q4 2024
  • In the last 5 years, Encompass Health's Equity Income had a median value of $900000.0 in 2021 and averaged $863157.9.
  • Per our database at Business Quant, Encompass Health's Equity Income soared by 20000.0% in 2023 and then plummeted by 7777.78% in 2024.
  • Quarter analysis of 5 years shows Encompass Health's Equity Income stood at $900000.0 in 2021, then plummeted by 66.67% to $300000.0 in 2022, then surged by 200.0% to $900000.0 in 2023, then tumbled by 77.78% to $200000.0 in 2024, then skyrocketed by 500.0% to $1.2 million in 2025.
  • Its Equity Income was $1.2 million in Q3 2025, compared to $1.4 million in Q2 2025 and $900000.0 in Q1 2025.